Xinxiang Central Hospital

Futó vizsgálatok

• Toboroz

  Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre

  NCT07687186· 3. fázis· Tasly Pharmaceutical Group Co., Ltd· Forrás

• Toboroz

  A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

  NCT07477587· 1. fázis· Shanghai Henlius Biotech· Forrás

• Toboroz

  A Study of E6742 in Participants With Systemic Lupus Erythematosus

  NCT07515014· 2. fázis· Eisai Co., Ltd.· Forrás

• Toboroz

  A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

  NCT07438496· 3. fázis· Janssen Research & Development, LLC· Forrás

• Toboroz

  A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

  NCT07361302· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  Efficacy and Safety of iGlarLixi Versus Standard of Care in a Real-world Adult China Population With Uncontrolled Type 2 Diabetes on Oral Agents

  NCT07307235· 4. fázis· Shanghai Zhongshan Hospital· Forrás

• Fut, nem toboroz

  Efficacy and Safety of Interleukin-6 Receptor Inhibitor Combined With Endovascular Treatment in Patients With Acute Anterior Circulation Large Vessel Occlusion Stroke -2

  NCT07263776· 3. fázis· Capital Medical University· Forrás

• Fut, nem toboroz

  A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)

  NCT07176390· 2. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

  NCT06935370· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic Retinopathy

  NCT06817265· 3. fázis· Beletalent (Zhuhai) Pharmaceutical Co., Ltd· Forrás

• Toboroz

  TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection

  NCT06829784· 3. fázis· Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.· Forrás

• Toboroz

  A Study of SCTB35 in Patients with Systemic Lupus Erythematosus

  NCT06841042· 1/2. fázis· Sinocelltech Ltd.· Forrás

• Még nem toboroz

  Nanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC Cachexia

  NCT06793228· 2. fázis· Henan Cancer Hospital· Forrás

• Fut, nem toboroz

  Nipocalimab in Moderate to Severe Sjogren's Disease

  NCT06741969· 3. fázis· Janssen Research & Development, LLC· Forrás

• Még nem toboroz

  The Survey of Treatment and Metabolic Status of Type 1 Diabetes Mellitus (T1DM).

  NCT06606509· Nanjing First Hospital, Nanjing Medical University· Forrás

• Fut, nem toboroz

  EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

  NCT06531824· 3. fázis· Boehringer Ingelheim· Forrás

• Toboroz

  A Phase I/II Study of FWD1802 in Patients With ER+/HER2- Advanced BC.

  NCT06064812· 1/2. fázis· Forward Pharmaceuticals Co., Ltd.· Forrás

• Fut, nem toboroz

  A Study to Evaluate the Efficacy and Safety of HLX11 vs. EU-Perjeta® in the Neoadjuvant Therapy of HER2-Positive and HR-Negative Early-stage or Locally Advanced Breast Cancer

  NCT05346224· 3. fázis· Shanghai Henlius Biotech· Forrás

• Még nem toboroz

  Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System

  NCT04995159· Lepu Medical Technology (Beijing) Co., Ltd.· Forrás

• Fut, nem toboroz

  A Phase III Clinical Trial of AK105 Injection Combined With Anlotinib Hydrochloride Capsules Versus Sorafenib in Subjects With Advanced Hepatocellular Carcinoma (HCC)

  NCT04344158· 3. fázis· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Lupus (SLE)3 toboroz
• Koszorúér-betegség2 toboroz
• Szívelégtelenség2 toboroz
• 1-es típusú cukorbetegség1 toboroz
• 2-es típusú cukorbetegség1 toboroz
• Asztma1 toboroz
• Áttétes emlőrák1 toboroz
• Diabéteszes retinopátia1 toboroz
• Mielóma multiplex1 toboroz
• Stroke (szélütés)1 toboroz
• Tüdőrák1 toboroz

Lezárt vizsgálatok

• Lezárult

  Phase IIa Study for IPG11406 in Patients With Lupus Nephritis

  NCT06717815· 1/2. fázis· Nanjing Immunophage Biotech Co., Ltd· Forrás

• Lezárult

  Intracranial Distal Access Catheter in Neurointerventional Therapy

  NCT06989931· MicroPort NeuroTech Co., Ltd.· Forrás

• Lezárult

  A Study to Evaluate Efficacy and Safety of Qingzhu Granules in the Treatment of Acute Gouty Arthritis

  NCT06068478· 3. fázis· Tasly Pharmaceutical Group Co., Ltd· Forrás

• Lezárult

  Outcomes After Intravenous Alteplase / Tenecteplase With or Without Shuxuetong Injection in Routine Clinical Practice

  NCT06018181· Dongzhimen Hospital, Beijing· Forrás

• Lezárult

  A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis

  NCT06068465· 3. fázis· Tasly Pharmaceutical Group Co., Ltd· Forrás

• Lezárult

  Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke

  NCT05631847· Sichuan Academy of Medical Sciences· Forrás

• Lezárult

  Evaluation of the Effect of Injectable Neucardin on Cardiac Function and Reversal Ventricular Remodeling in Patients With Chronic Systolic Heart Failure

  NCT05949801· 3. fázis· Zensun Sci. & Tech. Co., Ltd.· Forrás

• Lezárult

  rhPro-UK in Acute Ischaemic Stroke Within 4.5 Hours of Stroke Onset Trial 2(PROST-2)

  NCT05700591· 3. fázis· Tasly Biopharmaceuticals Co., Ltd.· Forrás

• Lezárult

  A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke

  NCT05686070· 3. fázis· Bayer· Forrás

• Lezárult

  Real-world Study on Edoxaban Treatment for Patients With Non-valvular Atrial Fibrillation in China

  NCT04747496· Daiichi Sankyo· Forrás

• Lezárult

  Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%

  NCT04435626· 3. fázis· Bayer· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Tourette syndrome4 munka · 0 vizsgálat